BG
Baylor Genetics Holdings, Inc.
SEC filingOther Health Care · Houston, TX
Amount raised$50Msold at filing
Total offering$100M$50M still open
Investors in the raise13count reported to the SEC
FiledJul 16, 2026first sale Jul 1, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Brendan LeeDirector
Xiangmin CuiDirector
Joel KaufmanExecutive Officer
Goki IshikawaDirector
Kengo TakishimaExecutive Officer, Director
Victor TongDirector
David BergerExecutive Officer
Executive officers, directors and promoters as listed on the Form D.